Neuromodulation and Private Practice: not an oxymoron
description
Transcript of Neuromodulation and Private Practice: not an oxymoron
![Page 1: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/1.jpg)
Neuromodulation and Private Practice: not an oxymoron
Mark Gudesblatt MD
South Shore Neurologic Associates
Suffolk County, Long Island, New York
![Page 2: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/2.jpg)
Know your diseases Know your options both as a clinician and as a patient Know your therapies Be the best you can, always give your best effort An uninformed advocate is not an effective advocate Neuromodulation: The best therapies that no one has
ever heard of Lack of awareness of treatment options is not the same
as lack of efficacy A treatment not utilized is a treatment not effective Not all treatments are appropriate for all patients Not all treatments produce desired outcomes
Summary for those who are hungry, like to read the end of the story first or leave early …
![Page 3: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/3.jpg)
“It’s hard to make predictions, especially about the future.” Yogi Berra
The Challenge of Predicting Prognosis, Treatment needs and response, and Disease Progression
![Page 4: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/4.jpg)
Classic Education, Traditional Care
Who are you as a clinician?
Who do you want to be as a clinician?
How do you get from where you are to where you might want to be?
“The times they are a changing…”
Concurrent & simultaneous evolution and revolution
![Page 5: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/5.jpg)
Neurology, Therapeutics, & The Concept of Actually Offering Treatment: Oxymoron?
Appreciation that the disease or symptoms are truly a problem for the patient
Accurate and comprehensive analysis of the problem or problems reported
Diagnosis of the disease problem followed by an actual interest and intent to treat
Identification of the issues that have a potential treatment and need to treat
Intention to treat followed by action and actual treatment Treatment & Intervention followed by ongoing care, monitoring
and management Not diagnose and adios
![Page 6: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/6.jpg)
What Neuromodulation therapies are available?
Are Neuromodulation therapies effective?
No therapy is effective for all patients
Goal setting: appropriate, realistic, mutually agreed upon
Inappropriate or unrealistic goals can lead to dissatisfaction and apparent therapy failure
Why offer Neuromodulation in general or private practice?
Why not?
Which Neuromodulation Therapy to offer in practice?
Neuro What?
![Page 7: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/7.jpg)
The first Neuromodulation clinical trial
![Page 8: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/8.jpg)
Why should these therapies be utilized?
Why should I do this?
Why shouldn't i do this?
How can I offer these treatments?
Why don’t others offer these treatments?
Which one(s) should I be involved with?
The Problem
![Page 9: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/9.jpg)
The North American Neuromodulation Society
![Page 10: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/10.jpg)
![Page 11: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/11.jpg)
![Page 12: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/12.jpg)
![Page 13: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/13.jpg)
Why is it a problem?
Lack of awareness at multiple levels Patient, family, caregiver, and staff fear Lack of knowledgeable advocacy of available effective
treatment Lack of comfort for patient, caregiver, and clinician in utilizing
“novel therapies” ITB therapy gained U.S. Food and Drug Administration (FDA) approval for
managing severe spasticity of spinal origin in 1992 ITB therapy gained U.S. Food and Drug Administration (FDA) approval for
managing severe spasticity of cerebral origin in 1996 The (FDA) approved DBS as a treatment for Essential Tremor in 1997,
for Parkinson’s Disease in 2002, and Dystonia in 2003 Physician fear and limited training in these therapies
Medical School, Residency, Fellowship, Post-graduate CME Lack of exposure
![Page 14: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/14.jpg)
Making the jump from diagnosing and implementation of standard neurological care models to awareness, offering and implementing available and effective or evolving therapies that have developed in the past 25 years can be a difficult transition.
Hakuna Matata – “change can be difficult” - Rafiki
![Page 15: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/15.jpg)
The Challenge of Fear
Address issues of fear Address issues of uncertainty Address issues of concern Address issues that arise Address lack of awareness Address misconceptions Address lack of exposure
With apologies to the movie
![Page 16: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/16.jpg)
Offering effective therapies often times requires more than just treatments administered orally.
To adequately and effectively address symptoms and to treat disease progression from some neurological disorders treatment requirements might include:
Parenteral or intravenous treatments
Intrathecal delivery of medication
Neuromodulation interventions.
![Page 17: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/17.jpg)
![Page 18: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/18.jpg)
Offering Hope can be contagious
Is an effective clinician something more than just a diagnostician?
Are you just a diagnostician or a clinician who will not only diagnose but manage the neurological disorder?
Are you a clinician that will only go so far in the care of your patients?
What is the role of advocacy in neurological care? What is the role of objective analysis?
![Page 19: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/19.jpg)
Effective disease management might require more than just standard traditional evaluations, treatments and interventions.
A comprehensive armamentarium of treatment opportunities offer more hope and options for effective and satisfying care than does limited choices or options.
As diseases evolve or progress treatment decisions and treatment requirement may become more complex.
Are you interested and ready to offer treatments that can be effective, dramatic and satisfying if they require more time, effort, and involvement beyond a prescription or a brief discussion?
What is comprehensive care?
![Page 20: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/20.jpg)
Flexibility is the name of the game
![Page 21: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/21.jpg)
What is in a name, anyway?
Evaluating care needs goes beyond a diagnosis or a disease name.
Disease management requires addressing not only the underlying disorder but as many of the concurrent associated symptoms or problems as possible.
These symptoms or problems may evolve or appear over time despite adequate use or adjustment of first line standard or conventional treatments.
![Page 22: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/22.jpg)
Parkinson’s Disease:What is in a name?
Treatment PlanCo-morbidities or
…Spectrum of diseaseAutonomicBP lability
Tremor vs. Akinetic Rigid
Freezing of Gait
CognitionMemory
Executive FunctionInformation Processing
AttentionApathy
PsychiatricAnxiety-depression
OCD-gamblingPanic
Sleep DisordersApnea
RLS/PLMSREM Sleep
Behavioral Disorder
Fall RiskAutonomicGI MotilityBalance
Vestibular
Fatigue
DystoniaDyskinesia
![Page 23: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/23.jpg)
As diseases evolve or progress treatment decisions and treatment requirement may become more complex.
Patient needs may change over time. What is a significant change or threshold of change that
needs to be addressed? Are you interested and ready to offer treatments that can
be effective, dramatic and satisfying if they require more time, effort, and involvement beyond a prescription or a brief discussion?
![Page 24: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/24.jpg)
Challenging Neurological Disorders may require adjunct use of novel technology or treatment
Identifying Appropriate Candidates or people in need who can benefit from neuromodulation They are really just all around …. Open your eyes Look, listen, question Just ask – be proactive Educate others Don’t be afraid to advocate or discuss options
![Page 25: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/25.jpg)
Effective disease management might require more than just standard traditional evaluations, treatments and interventions or oral medications.
Effective evaluations and treatments of complex and evolving or progressing neurological disorders might require an arsenal of analysis, documentation, and treatment methods and tools.
Objective documentation of change is better than a subjective report
A comprehensive armamentarium of treatment opportunities offer more hope and options for effective and satisfying care than does limited choices or options.
![Page 26: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/26.jpg)
The Challenge of Patient Selection
Successful patient selection simply starts with awareness of therapeutic options
Awareness starts with education, hope, proactive concern and communication as well as elimination of the concept of therapeutic nihilism.
Demystification of “Neuro-mythology” lack of effective and available treatment options.
Be proactive, be involved
ITB
![Page 27: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/27.jpg)
“The more convincing you have to do to get a patient to undergo a screening test, the less likely the patient is to be satisfied with the outcome.”
Janet Gianino, R.N., M.S.N.Rush-Presbyterian-St. Luke’s Medical Center, Chicago
No matter what the therapy is….
![Page 28: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/28.jpg)
Treatment team must continuously work closely with patients, families/caregivers to establish functional goals tailored to the patients level of disability and reinforce them post-implant
Goals should be realistic, reasonable, explicit, mutually agreed upon, collective, and established prior to intervention
Patience is needed to achieve goals Unstated and/or unrealistic expectations and impatience
can lead to disappointment and perceptions of treatment failure
Communication is key It is not the speed of adjustment or reprogramming but
achieving the goals desired
The Challenge of Effective Communication
![Page 29: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/29.jpg)
Communication is a 2 way street
![Page 30: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/30.jpg)
Patience, Patient, Patients
The challenge of being a patient, encouraging, proactive advocate, communicator and clinician
The challenge of being a reasonable, reliable, responsible, and patient patient
The challenge of being a reasonable, reliable, responsible, and patient caregiver
Put yourself in someone else’s shoes Let the patient and family/care-giver be your guide Let the clinician be your guide Opportunities for trust and cooperation are all around Make allies not enemies
![Page 31: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/31.jpg)
Program development is a process
Evolution takes time (just ask Darwin)
The “what is needed or not” changes with time, clinical experience, and patient needs
Treatment or therapeutic interventions require modification over time to address patient needs that "appear" or develop
Experience and awareness of what is needed for effective & satisfying implementation develops over time
A vision for a Neuromodulation center or team is modified and achieved over time
![Page 32: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/32.jpg)
agree
disagree
referralClinic
SSNA identify appropriate candidate
SpecialtyConsult
regarding candidacy
Pre-implant testing
Surgicalimplant
post-implant Initial
Programming
establish plan of care,
communicate
Ongoing local Care
reprogamming
Rehab
One practice practical approach
![Page 33: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/33.jpg)
Teamwork and Communication are key Can comprehensive care be delivered in isolation by one
clinician? Experienced Implanter and Team
Deciding on roles for MD, NP, PA and RN partners in care: what are the personalities and work relationship of team
members ...
Effective ongoing communication In-Network insurance coverage Follow plan of care Co-management with seamless cooperation and communication
offers better care opportunities and all providers have improved satisfaction and likely improved outcomes What can you do to improve care efficacy & efficiency?
Trouble shooting
![Page 34: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/34.jpg)
One Example: The Challenge of An Effective ITB Trial
Goal setting prior to ITB trial Mutually agreed upon, appropriate, collective, realistically
obtainable goals Choosing dose to administer Outcome goals to be measured at ITB trial Allaying patient & care-giver fear of test dose Educating regarding effective spasticity management
![Page 35: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/35.jpg)
Goals of ITB Therapy
Predictable Reduce tone in extremities Reduce spasms in
extremities or trunk Control clonus in extremities Reduce spasticity-related
pain Improve sleep Reduce side effects of oral
antispasmodic medications Improve quality of life Ease care giving tasks,
performance of hygiene, dressing, bathing
Ease positioning in wheelchair
Unpredictable Improve quality of gait Reduce spasticity-related
pain with ambulation Increase independence in
transfers Increase upper extremity
control and function Improve bladder and bowel
function Reduce incidence of skin
breakdown Improve oral motor control
and vocal cord dysfunction
Barbara Ridley, Patrice Korth Rawlins, Intrathecal Baclofen Therapy: Ten Steps Toward Best Practice. Journal of Neuroscience Nursing, April 2006 Volume 38, Number 2
![Page 36: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/36.jpg)
Potential Goals: keep it simple
ITB goals
ITB
![Page 37: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/37.jpg)
Goals must be: Reasonable, realistic, mutually agreed upon Not all goals identified and planned for might be achieved Goal setting can be modified ongoing or after
implementation of neuromodulation Feedback from patient, care-giver, staff, therapist is
important Communication to set or change goals Clinician: Let the patient, family, caregiver be your guide Patient/Family: Let the clinician be your guide Put yourself in someone else’s shoes Opportunities for trust, communication and cooperation are
everywhere, and must be identified and pursued
![Page 38: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/38.jpg)
Experience does count: if I can do this so can you.
Learning from each exposure leads to experience
![Page 39: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/39.jpg)
Practice Does Improve Clinician Confidence & Performance
Neuromodulation
DBS Implant
![Page 40: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/40.jpg)
Roles constantly change and evolve
MD ITB involvement >15 years, >250 active ITB pumps, >350 ITB trials
MD initially - initial evaluation, trial, post trial review, post implant adjust, refills & adjustment, house calls
NP involvement – teamwork and close involvement >10 years with ongoing collective discussions and co-management
MD or NP currently does initial spasticity evaluation; trial done together (MD does LP and injection), post ITB trial review and initiation of plan of care (NP), post implant adjustment & refills (NP), trouble shooting with catheter line check (NP)
![Page 41: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/41.jpg)
“We need a plan.”
![Page 42: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/42.jpg)
Effective treatment is often not accomplished in a single office visit. Not all issues can be addressed in one visit
Effective treatments require consideration, communication, thought, comprehensive care, ongoing care, feedback and concerned proactive management. Did it work out for you or not?
What is comprehensive care? What is the standard of care? Are all current care guidelines appropriate and up to
date?
![Page 43: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/43.jpg)
Therapy availability, access, implementation and ongoing management and adjustment should be seamless.
Know your resources
Teamwork
Promote ease of access and community awareness
Continuity of providers and communication offers an effective avenue and opportunity for satisfying care delivery and collaboration
![Page 44: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/44.jpg)
Post-implant Plan of Care
• Reassess adjunctive therapies
• Modify procedure/dose• Reevaluate patient
selection/goals
Yes No• Continuous
reevaluation at follow-up to review
– treatment strategy– Reassessment of
adjunctive therapiesBrin MF et al. Muscle Nerve. 1997;20(suppl 6):S208-S220.
Review outcomes: Were functional objectives met?
Physician extenders can help coordinate and effectively implement the plan of care
![Page 45: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/45.jpg)
The Challenge of Individualization of any Neuromodulation Therapy
Post implant management is not just about dose adjustments, refills, or change in stimulator settings
Individualized dosing patterns and speed of titration or adjustment that enhance patient satisfaction and outcomes should be used
Neuromodulation is a program, not simply just a procedure
![Page 46: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/46.jpg)
The Challenge of Setting Appropriate & Effective Goals Post Implant
Improve ease of care & comfort Improve function and or independence Prevent deformity or contracture Pick another goal Clarify expectations Realistic and individualized for each patient Commitment, understanding, motivation Document Change and response
![Page 47: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/47.jpg)
Establishing liaisons and relationships with company representatives and academic centers
Education if exposure did not occur during training Expand and increase awareness of options for effective therapy
utilization Help identifying candidates for appropriate effective treatment Advocacy Developing awareness of availability of an effective therapy and
awareness of local expertise. Not all centers do all aspects of treatment from implementation,
evaluation, goal setting, screening for candidacy, trial or implant, post implant management (early vs. late)
Co-management can be effective for not only refining care needs but transitioning and optimizing patient care from tertiary centers back to the community for local care.
![Page 48: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/48.jpg)
ITB
Initial spasticity evaluation and determining plan of care ITB trial- goal setting, education, evaluation of response Post trial review, education, and confirming plan of care Coordinating plan of care Post implant adjustment, monitoring and management Refills Trouble shooting
Office issues & catheter dye studies
![Page 49: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/49.jpg)
DBS - VNS
Co-management of care When to be seen in the office again Establish a plan of care Flexibility is important
Identification of candidates DBS:ET, PD vs atypical PD, Dystonia, ? Other VNS: refractory, not surgical candidate, organic epilepsy Inclusion vs exclusion Goal setting must be appropriate
Education Post-implant programming or ramp-up and review of
clinical response or therapeutic gains
![Page 50: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/50.jpg)
Neuromodulation Reprogramming & Fear: Error messages you will not see..
Adjustable, Reversible, not permanent or destructive There is no Geek Squad to call but technical services can
be helpful Before any change the message will remind you .. Are
you certain you want to do that? .. Stop and think …
![Page 51: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/51.jpg)
Post implant management (surgical – wound issues by NSG), post implant initial programming and determination of initial responses (MP)
After several adjustments (MP) notes sent back to us and patient referred back for ongoing care and reprogramming
Initial return reprogramming (initially MD -> over time MD or NP for initial visit and ongoing reprogramming) – and if need be for trouble shooting additional opinion (MP)
Visit for DBS PD-ET management includes history, examination, and reprogramming Code for procedure, length of time, complex office visit
![Page 52: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/52.jpg)
Different diagnosis – Same overall plan of co-management: team care
Epilepsy care – ongoing management (MD or NP) Refractory Epilepsy – adjustment of medications/doses
and determination of care plan (MD & NP) – co-management
EMU referral (MD or NP) Post EMU evaluation and decision management (MD or
NP) VNS implant referral and post implant programming (MD
or NP) VNS programming ramp up (NP) Office visit – history, examination, VNS reprogramming
Complex visit, procedure code Duration of visit predicated on needs of patient and care
![Page 53: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/53.jpg)
Special considerations on management of Neuromodulation patients
Obsessive behavior regarding control of care Deciding on roles for MD, NP, PA and RN
partners in care: what are the personalities and work relationship of team members ...
experience, interest, training Time management and complex patients
?how much time is needed how much time do you have?
which clinician co-management What are the roles of ancillary clinicians to help with
time, access to care, and clinical management What can you do to improve care efficacy & efficiency?
![Page 54: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/54.jpg)
One clinician to address and review plan of care and assess response to dose adjustment.
How much time is needed for history, evaluation of spasticity response to treatment, clinical examination, ITB refill and adjustment by reprogramming? High level of complexity of service Bill for prolonged time of service if needed Bill for office visit and procedure code Bill for medications (buy & bill) depending upon
insurance Medtronic has reimbursement specialist to help with
this Spasticity management evaluation separate from routine
care evaluation (specialty visit)
![Page 55: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/55.jpg)
The financial considerations and opportunities of Neuromodulation
Effective therapy can be safe and rewarding both personally, professionally as well as financially.
You cannot offer a therapy that is - not effective, not safe, not insurance covered, and not fiscally viable.
Schedule The examination will vary with experience of the clinician How much time do you need to discuss the diagnosis/differential
diagnosis, plan of evaluation and treatment plan?
Visits: (average) CNC.................................30 minutes OV....................................15 minutes Re-evaluation...................30 minutes Specialty Clinics CNC.......45 minutes Specialty OV....................30 minutes
![Page 56: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/56.jpg)
ITB: (per visit/per unit) not including visit code 62368 Analysis reprogramming (no drugs)……….......... $ 58.65 62369 refill/programming by non MD...............................$107.57 62370 refill/programming by an MD.................................$133.56 (95990 and 95991) refill/programming prior to 1/1/2012..$ 72.39 J0475 baclofen Lioresal per unit.......................................$189.89 J0475 Gablofen per unit....................................................$137.67
![Page 57: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/57.jpg)
DBS: (per) not including visit code 95970 w/o reprogramming.........................................$ 55.47 95978 programming 1st hour....................................
$232.66 95979 programming each add'tl 1/2 hour.................$180.37
VNS: (per) not including visit code 95970 w/o reprogramming.........................................$ 55.47 95974 programming 1st hour....................................
$170.02
![Page 58: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/58.jpg)
South Shore Neurologic Associates: A comprehensive private practice
Diagnosis: accurate diagnosis by history, examination and relevant diagnostic testing.
Computerized Cognitive Testing, Electrodiagnostic testing, Evoked Potentials, MRI, PET, EMU, Transcranial Doppler (bubble tests), Vestibular Testing, Polysomnography, Autonomic Testing. Epilepsy Monitoring Unit
Treatment: effective treatment to target disease and associated symptoms. Ongoing disease monitoring and management. If appropriate offering treatment with Interventional Neurology with
Neuromodulation ITB, DBS, VNS, Neurotoxin, Functional Electric Stimulation, Peripheral
Nerve Stimulation, Interventional Pain management (epidural injections, facet blocks, nerve blocks)
Liberatory Maneuvers for particle repositioning, Acupuncture Infusion services (Tysabri, Remicade, Rituxan, IVIG, Steroids) Capture of objective metrics of disease by computerized analysis (gaitrite,
smart balance master, computerized cognitive testing
![Page 59: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/59.jpg)
Neuromodulation Made Easy
Neuromodulation
For
DUMMIES ITB
There is so much Neuromodulation to learn. It should be this easy….
Know your resources
Use your resources
DBSDBS
![Page 60: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/60.jpg)
The Challenge of just taking that step, others will be glad you did as treatments have evolved …
Be an effective therapeutic leader Be a Neuromodulation champion Offer hope and accurate information Offer appropriate knowledgeable advocacy Offer safe, effective, available and satisfying treatment
for a problem that is often under “appreciated”, under-treated and in general treated ineffectively and with poor patient and clinician satisfaction
![Page 61: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/61.jpg)
The best may be yet to come…
Development of novel therapeutics targeted for specific genetic or immune disorders
Delivery of novel therapeutics may require novel methods
Objective measures to accurately assess disease change or response to treatments.
Objective metrics to validate therapies and responses with clinically meaningful correlates and identified economic impact
![Page 62: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/62.jpg)
Learning from others can make the experience more rewarding both personally and professionally
Special Thank you to those who helped with the process SSNA: Carol Seidel, Barbara Bumstead, Cliff Miller,
Laura Buck, Patricia Grant Physicians: Alon Mogilner, Michael Pourfar, Ron Alterman,
Jeff Epstein, Melinda Morrissey, Hu Xian Industry: Victor Vozzo, Therese LaSpisa, Joseph Pagano,
Lee Calves, Jill Guimont, Linnea Burman, Shirley Picka, Susan Johnson
![Page 63: Neuromodulation and Private Practice: not an oxymoron](https://reader036.fdocuments.in/reader036/viewer/2022081516/568139fc550346895da1c084/html5/thumbnails/63.jpg)
My brain is full of neuromodulation